Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9570-9577
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9570
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9570
Table 1 Patient characteristics
| Number of cases | 30 |
| Age (yr) | 64.3 ± 1.5 SD |
| Sex (M/F) | 9/11 |
| Performance status (0/1/2/3/4) | 18/8/ 3/1/0 |
| Location (head/uncus/body/tail/others) | 13/4/9/1/ 3 |
| Mean tumor size (mm) | 31.67 ± 1.7 SD |
| Pre-therapy (operation/chemotherapy/radiation/IVR/BSC) | 3/28/4/5/1 |
- Citation: Sofuni A, Moriyasu F, Sano T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, Umeda J, Tonozuka R, Honjo M, Mukai S, Fujita M, Itoi T. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol 2014; 20(28): 9570-9577
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9570.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9570